Cell
Therapeutics, Inc. (NASDAQ:CTIC) surged 1.84% to $0.382. Cell
Therapeutics, Inc. develops, acquires and commercializes treatments for cancer.
It focuses on building a biopharmaceutical company with a diversified portfolio
of oncology drugs. Its research, development, acquisition and in-licensing
activities concentrate on identifying and developing less toxic ways to treat
cancer.
Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) slid 0.12% to $12.68. The
52-week range of the stock is $9.51-$24.21.
Amylin
Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company engaged in
discovery, development and commercialization of medicines. The Company is
marketing two first-in-class medicines to treat diabetes, BYETTA (exenatide)
injection and SYMLIN (pramlintide acetate) injection.
PharmAthene,
Inc. (AMEX:PIP) is up 2.82% to $3.65. The 52-week range of the
stock is $1.13-$4.96. The stock is up more than 85% year-to-date.
PharmAthene,
Inc. is a biodefense company engaged in the development and commercialization
of medical countermeasures against biological and chemical weapons.
Article published by Wall Street Grand. Visit the Wall Street Grand Club today. For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
